ACGT_News_CancerEmperor_226x134

March 26, 2015

TV Documentary features ACGT Researcher & Patient

Mark your calendars to watch Emperor of All Maladies on PBS (CPTV) on March 30, 31 and April 1, 2015 from 9-11pm. This series, presented by documentary filmmaker Ken Burns, is based on the 2010 Pulitzer Prize-winning book The Emperor of All Maladies: … Read More

Photo from HBO Vice

March 2, 2015

ACGT Scientists Featured In HBO Special: Killing Cancer

HBO Documentary Series, Vice, aired an episode on February 27th entitled, “Killing Cancer,” focusing on how different viruses are being used successfully as “weapons” to target cancer.  The program focuses on 2013 ACGT Grantee Dr. John Bell, for his work … Read More

Chen in the lab

January 15, 2015

Tackling Cancer with a New Paradigm

Dr. Lieping Chen, a founding member of the ACGT Scientific Advisory Council, is one of the very early pioneers in the field of pd-1 inhibitors, which has now led to the September, 2014 FDA approval of Keytruda for treating advanced melanoma. In … Read More

Bob Nevis, On Par

January 16, 2015

Back on Par

In 2012, Bob Levis, an Allentown, Pennsylvania resident, believed he had come to the end of his life. Diagnosed in 2002 with chronic lymphocytic leukemia, the cancer had resisted every possible treatment and had infiltrated his bone marrow, paralyzing his … Read More

Lung Cancer

February 26, 2014

Dr. Jack Roth’s Patient with Adenocarcinoma

I am an almost five year survivor of Stage IV NSCLC, adenocarcinoma. I attribute this amazing achievement to the grace of God, aggressive treatment and a “no stone left unturned” attitude. This attitude led me years ago to ACGT and the pioneering work of people like Dr. Jack Roth. Read More

ACGT

December 1, 2013

By the Numbers

ACGT is the nation’s only non-profit exclusively dedicated to gene and cell therapies for treating cancer.  To date, ACGT has provided over $24 million in grants to top oncologists and funded breakthrough clinical trials that save lives.  Learn more about ACGT … Read More

Dr. Sadelain

October 17, 2013

Future of Gene Therapy

Dr. Michel Sadelain, ACGT Research Fellow, talks about the future of gene therapies for cancer treatment. When/Where: Alliance for Cancer Gene Therapy’s (ACGT) “Achieving Cancer Remission With Cell And Gene Therapies” held October 2013 at the Harvard Club in NYC. … Read More

Dr. Laurence Cooper

October 17, 2013

Philanthropy Key to Fighting Cancer

Dr. Laurence Cooper, ACGT Research Fellow, emphasizes the need for philanthropy and private funding in the fight against cancer. . When/Where: Alliance for Cancer Gene Therapy’s (ACGT) “Achieving Cancer Remission With Cell And Gene Therapies” held October 2013 at the … Read More

The mission of ACGT is to seek out and support revolutionary scientific research into the causes, treatment and prevention of all types of cancer using cells and genes as medicine.

Cell and gene therapies are destroying tumors every day in the laboratory and in human trials, targeting only the cancer with few side effects to healthy tissue.  ACGT’s rigorous grant review process, under the guidance of a preeminent Scientific Advisory Council,  have resulted in some of the most successful breakthroughs in the history of cancer treatments and led to many patients in complete remission.

100% of our funding supports innovation and translational science that is proving again and again to offer better treatment options than the traditional therapies of chemotherapy, surgery and radiation. Every donation brings us closer to saving lives and changing the way we treat cancer forever.